MEETING CANCELLED: Plant Genome Engineering: From Lab to Field Organizer(s): Caixia Gao, Daniel F. Voytas and Holger Puchta Date: April 03 - 06, 2020 Location: Beaver Run Resort, Breckenridge, CO, USAFor important information on the coronavirus, please click hereImprovements in plant breeding are necessary to feed a growing population on a warming globe. CRISPR/Cas technology, which is revolutionizing molecular biology, has the potential to create a novel, sustainable agriculture. To date, thousands of plant biologists have started to use gene editing strategies; the time is ripe for a conference solely dedicated to CRISPR/Cas applications in plants. Topics covered will include the development of new tools for gene and base editing, gene targeting by homologous recombination, transcriptional regulation, epigenetic editing and induced chromosomal rearrangements. To apply these tools in plants, specific biological requirements have to be taken into account such as efficient transformation and regeneration procedures or organ specific expression. Trait improvements in crop plants - such as tomato, rice, wheat and corn - have been achieved and more are in the pipeline. The conference will be a platform for scientists from academia and industry to interact. It will also bring together scientists that work on tool development, plant transformation, plant breeding and crop trait development. Thus, not only will the newest applications of CRISPR/Cas in basic plant biology be offered, but the ground will be laid for a swift transfer of the benefits of the technology to that field. Meeting has been cancelled. Please call our office if you have questions at 970-262-1230 or 1-800-253-0685.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
CORTEVA Agriscience
Pairwise
Pfizer Inc.
We gratefully acknowledge the generous grant for this conference provided by: National Science Foundation (NSF)Grant No. IOS_1942422 Funding for this conference was made possible (in part) by IOS_1942422 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |